D.E. Shaw & Co
MDRX

D.E. Shaw & Co’s Veradigm Inc. Common Stock MDRX Stock Holding History

D.E. Shaw & Co’s Portfolio MDRX Stock Details MDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,398,754
Closed -$35.7M – 4887
2023
Q4 		$35.7M Sell
3,398,754
-235,484
-6% -$2.89M 0.03% 608
2023
Q3 		$47.8M Sell
3,634,238
-182,417
-5% -$2.39M 0.05% 443
2023
Q2 		$48.1M Buy
3,816,655
+280,302
+8% +$3.4M 0.05% 448
2023
Q1 		$46.1M Sell
3,536,353
-4,469
-0.1% -$72.4K 0.05% 452
2022
Q4 		$62.5M Buy
3,540,822
+447,619
+14% +$7.5M 0.07% 346
2022
Q3 		$47.1M Sell
3,093,203
-677,996
-18% -$11M 0.06% 430
2022
Q2 		$55.9M Sell
3,771,199
-624,828
-14% -$11.7M 0.07% 352
2022
Q1 		$99M Buy
4,396,027
+1,015,591
+30% +$20.6M 0.09% 235
2021
Q4 		$62.4M Sell
3,380,436
-1,163,233
-26% -$18.5M 0.05% 449
2021
Q3 		$60.7M Buy
4,543,669
+107,078
+2% +$1.73M 0.05% 439
2021
Q2 		$82.1M Sell
4,436,591
-500,298
-10% -$8.42M 0.07% 336
2021
Q1 		$74.1M Buy
4,936,889
+1,835,587
+59% +$29.4M 0.07% 330
2020
Q4 		$44.8M Buy
3,101,302
+125,307
+4% +$1.52M 0.04% 543
2020
Q3 		$24.2M Sell
2,975,995
-235,361
-7% -$1.92M 0.02% 733
2020
Q2 		$21.7M Buy
3,211,356
+311,546
+11% +$2.02M 0.03% 733
2020
Q1 		$20.4M Sell
2,899,810
-890,555
-23% -$7.23M 0.03% 607
2019
Q4 		$37.2M Buy
3,790,365
+155,329
+4% +$1.64M 0.04% 518
2019
Q3 		$39.9M Sell
3,635,036
-462,184
-11% -$4.74M 0.05% 460
2019
Q2 		$47.7M Sell
4,097,220
-327,765
-7% -$3.33M 0.06% 390
2019
Q1 		$42.2M Buy
4,424,985
+1,035,753
+31% +$11.4M 0.05% 428
2018
Q4 		$32.7M Sell
3,389,232
-224,005
-6% -$2.5M 0.05% 491
2018
Q3 		$51.5M Buy
3,613,237
+522,124
+17% +$7.09M 0.06% 390
2018
Q2 		$37.1M Buy
3,091,113
+39,366
+1% +$485K 0.05% 458
2018
Q1 		$37.7M Sell
3,051,747
-689,149
-18% -$9.79M 0.05% 430
2017
Q4 		$54.4M Buy
3,740,896
+517,605
+16% +$7.19M 0.08% 329
2017
Q3 		$45.9M Buy
3,223,291
+1,411,268
+78% +$18.3M 0.07% 343
2017
Q2 		$23.1M Sell
1,812,023
-1,175,908
-39% -$14.3M 0.04% 536
2017
Q1 		$37.9M Buy
2,987,931
+119,013
+4% +$1.41M 0.07% 354
2016
Q4 		$29.3M Buy
2,868,918
+747,447
+35% +$8.53M 0.05% 479
2016
Q3 		$27.9M Sell
2,121,471
-213,055
-9% -$2.85M 0.05% 461
2016
Q2 		$29.6M Sell
2,334,526
-29,198
-1% -$387K 0.05% 416
2016
Q1 		$31.2M Sell
2,363,724
-134,630
-5% -$1.77M 0.06% 397
2015
Q4 		$38.4M Buy
2,498,354
+257,187
+11% +$3.69M 0.06% 389
2015
Q3 		$27.8M Buy
2,241,167
+1,331,874
+146% +$18.3M 0.04% 497
2015
Q2 		$12.4M Buy
909,293
+572,301
+170% +$7.73M 0.02% 893
2015
Q1 		$4.03M Buy
336,992
+170,513
+102% +$2.08M 0.01% 1518
2014
Q4 		$2.13M Sell
166,479
-1,192,910
-88% -$15.2M ﹤0.01% 2233
2014
Q3 		$18.2M Buy
1,359,389
+386,386
+40% +$5.86M 0.02% 747
2014
Q2 		$15.6M Buy
973,003
+846,434
+669% +$13.2M 0.02% 828
2014
Q1 		$2.28M Sell
126,569
-40,089
-24% -$693K ﹤0.01% 2255
2013
Q4 		$2.58M Sell
166,658
-283,999
-63% -$4.18M ﹤0.01% 2277
2013
Q3 		$6.7M Sell
450,657
-174,604
-28% -$2.63M 0.01% 1337
2013
Q2 		$8.09M Buy
+625,261
New +$8.38M 0.02% 1011

Other funds holding MDRX

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co's MDRX Position: Q1 2024 in Review

D.E. Shaw & Co sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 3,398,754 shares — an estimated $35.7M sold.

D.E. Shaw & Co first reported a position in MDRX in Q2 2013 and held it in 43 quarters. The position peaked at $99M in Q1 2022. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.

  • D.E. Shaw & Co reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 3,398,754 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $35.7M.
  • D.E. Shaw & Co first reported a position in Veradigm Inc. Common Stock in Q2 2013 and held it in 43 quarters.
  • D.E. Shaw & Co's Veradigm Inc. Common Stock position peaked at $99M in Q1 2022.
  • 35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.